Psychoactive substances, users and markets: recent trends (2017-2018)

 

eftacgyc.jpg

Tendances n° 129, OFDT, 8 p.
December 2018

Since 1999, the Emerging Trends and New Drugs (TREND) scheme of the French Monitoring Centre for Drugs and Drug Addiction (OFDT) has been monitoring emerging trends and phenomena in the field of drugs in order to limit the time between their occurrence and their consideration by the public authorities. The TREND scheme therefore provides a focus on people with high uses of psychoactive products. It is mainly based on qualitative data collected by the TREND sites network, located in eight metropolitan areas.

This issue highlights the developments that have particularly marked 2017 and the beginning of 2018:

  • the impact of the unprecedented accessibility to cocaine, including in the form of crack cocaine,
  • the fluidity between techno scenes and the crossovers of different party populations,
  • the increase in the visibility of GHB-GBL use in party settings with lots of incidences of intoxication,
  • the trivialisation of popper use in increasingly diverse user groups,
  • and finally, the slowing down of the emergence of new psychoactive substances (NPS), while their distribution seems to be focused on specific user profiles.

The second part is about continuing phenomena that have already been described in previous years, but that are still thriving: the integration of "chemsex" practices, the popularity of ecstasy tablets, the increase in the availability and visibility of ketamine use and the dynamic heroin supply.

Authors : Clément Gérome, Agnès Cadet-Taïrou, Michel Gandilhon, Maitena Milhet, Magali Martinez, Thomas Néfau

Download the PDF file (463 Ko)

 

 

 

 

 

 

 

Drugs in Europe


2019 EMCDDA European Drug Report

miniEDR2019s.jpgWhat do the latest data tell us about the European drug market? What are the new trends in drug use among European adults and school students? What are the harms associated with drug use and what is being done to counter them? These and other questions are explored in the 2019 EMCDDA European Drug Report.

  Country drug reports 2019

miniCountryProfiles.jpgDeveloped by the EMCDDA, in cooperation with the Reitox national focal points, these graphic-rich reports cover: drug use and public health problems; drug policy and responses and drug supply.

The European Union and the drug phenomenon

miniFAQDrugsEurope.jpgThe European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.